Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)

NCT04863703 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis D
Hepatitis B
Portal Hypertension
Liver Cirrhosis

Interventions

DRUG: Bulevirtide

Sponsor

Hannover Medical School